Key Segments:
By Clinical Trial Phase
-
Phase I
-
Phase II
-
Phase III
By Therapeutic Application
-
Oncology
-
Cardiovascular Disease
-
Neurological Disorders
-
Other Diseases
By End Use
-
Pharmaceutical Companies
-
Academic & Research Institutes
-
Other End Users
By Component
-
Software
-
Services
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market includes Tempus AI, Unlearn.ai, Medidata, IQVIA, Median Technologies, Medable, Fortrea, Worldwide Clinical Trials, Phesi, Saama, Parexel, Lindus Health and PathAI, among others.
The main opportunities lie in large pharmaceutical companies acquiring specialist AI trial-technology vendors, and in vendors securing formal biomarker and tool qualification status with drug regulatory authorities.
The key growth factor is the persistent clinical trial recruitment bottleneck, combined with rising pharma and CRO investment in AI-based trial technology platforms.
By clinical trial phase, the Phase II segment dominated the market with approximately 45.50% share in 2025, supported by its scale and enrollment complexity.
North America dominated the market with approximately 43.50% share in 2025, supported by its dense concentration of sponsors and AI vendors. Asia Pacific is the fastest-growing region with a projected CAGR of approximately 27.20% from 2026 to 2035.